KBH.NYSEKb Home

Form 4: KB Home Executive Brian Woram Receives Restricted Stock Grant

Sentiment:

SEC Form 4 Filing


📋All filings for Kb Home

EVP and General Counsel of KB Home, Brian J. Woram, received a grant of 1,032 shares of restricted common stock as part of his 2024 fiscal year annual incentive award.

Summary

  • Brian J. Woram, EVP and General Counsel of KB Home, filed a Form 4 to report changes in beneficial ownership.
  • On January 23, 2025, Woram received 1,032 shares of restricted common stock.
  • This grant is part of his 2024 fiscal year annual incentive award.
  • The restricted stock vests in three equal annual installments starting January 25, 2026, and continuing on January 25, 2027, and January 25, 2028.
  • Following the transaction, Woram directly owns 175,942 shares of KB Home common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation matter, which is generally neutral to slightly positive as it incentivizes management. The sentiment is moderately positive as it indicates continued investment in key personnel.

Positives

  • The grant of restricted stock aligns Woram's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting schedule of the restricted stock suggests an expectation of continued service and contribution from the executive over the next three years.

Industry Context

Equity compensation, such as restricted stock grants, is a common practice in the homebuilding industry to incentivize and retain key executives.

Comparison to Industry Standards

  • Comparing KB Home's executive compensation practices with those of peers like D.R. Horton (DHI), Lennar (LEN), and PulteGroup (PHM) would provide a benchmark for assessing the competitiveness and appropriateness of the equity grants.
  • Analyzing the vesting schedules and grant sizes relative to company performance and executive responsibilities would offer further insights.
  • Reviewing proxy statements of these comparable companies would reveal details of their executive compensation packages.

Stakeholder Impact

  • Shareholders may view the grant as a positive sign of aligning management's interests with long-term company performance.
  • Employees may see this as a positive sign of the company investing in its leadership.

Key Dates

DateDescription
01/23/2025Date of transaction: Grant of restricted common stock.
01/25/2026First vesting date of the restricted common stock.
01/25/2027Second vesting date of the restricted common stock.
01/25/2028Third vesting date of the restricted common stock.
01/27/2025Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.